A detailed history of Deutsche Bank Ag\ transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 238,951 shares of BPMC stock, worth $21.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
238,951
Previous 220,031 8.6%
Holding current value
$21.6 Million
Previous $23.7 Million 6.84%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$84.1 - $120.5 $1.59 Million - $2.28 Million
18,920 Added 8.6%
238,951 $22.1 Million
Q2 2024

Aug 14, 2024

BUY
$85.18 - $108.78 $7.97 Million - $10.2 Million
93,564 Added 73.98%
220,031 $23.7 Million
Q1 2024

May 15, 2024

SELL
$73.17 - $99.79 $1.2 Million - $1.63 Million
-16,368 Reduced 11.46%
126,467 $12 Million
Q4 2023

Feb 14, 2024

BUY
$43.96 - $92.84 $2.65 Million - $5.6 Million
60,268 Added 72.99%
142,835 $13.2 Million
Q3 2023

Nov 09, 2023

BUY
$46.9 - $66.0 $178,454 - $251,130
3,805 Added 4.83%
82,567 $4.15 Million
Q2 2023

Aug 14, 2023

SELL
$42.2 - $66.37 $1.19 Million - $1.87 Million
-28,246 Reduced 26.4%
78,762 $4.98 Million
Q1 2023

May 15, 2023

BUY
$37.97 - $50.0 $827,404 - $1.09 Million
21,791 Added 25.57%
107,008 $4.81 Million
Q4 2022

Feb 13, 2023

SELL
$41.06 - $66.48 $4.11 Million - $6.66 Million
-100,195 Reduced 54.04%
85,217 $3.73 Million
Q3 2022

Nov 14, 2022

SELL
$49.93 - $77.7 $460,803 - $717,093
-9,229 Reduced 4.74%
185,412 $12.2 Million
Q2 2022

Aug 11, 2022

SELL
$45.23 - $70.15 $154,957 - $240,333
-3,426 Reduced 1.73%
194,641 $9.83 Million
Q1 2022

May 13, 2022

SELL
$54.1 - $110.08 $184,913 - $376,253
-3,418 Reduced 1.7%
198,067 $12.7 Million
Q4 2021

Feb 11, 2022

SELL
$94.25 - $115.99 $21.4 Million - $26.3 Million
-226,543 Reduced 52.93%
201,485 $21.6 Million
Q3 2021

Nov 04, 2021

SELL
$80.98 - $109.47 $312,582 - $422,554
-3,860 Reduced 0.89%
428,028 $44 Million
Q2 2021

Aug 11, 2021

BUY
$82.78 - $101.0 $5.12 Million - $6.25 Million
61,832 Added 16.71%
431,888 $38 Million
Q1 2021

May 13, 2021

SELL
$90.71 - $108.28 $4.83 Million - $5.77 Million
-53,295 Reduced 12.59%
370,056 $36 Million
Q4 2020

Feb 16, 2021

SELL
$92.08 - $124.48 $238,395 - $322,278
-2,589 Reduced 0.61%
423,351 $47.5 Million
Q3 2020

Nov 12, 2020

SELL
$66.45 - $92.7 $3.81 Million - $5.32 Million
-57,397 Reduced 11.88%
425,940 $39.5 Million
Q2 2020

Aug 13, 2020

BUY
$57.09 - $79.27 $7.56 Million - $10.5 Million
132,374 Added 37.72%
483,337 $37.7 Million
Q1 2020

May 14, 2020

BUY
$48.11 - $82.22 $2.67 Million - $4.57 Million
55,537 Added 18.8%
350,963 $20.5 Million
Q4 2019

Feb 14, 2020

SELL
$66.73 - $82.59 $447,224 - $553,518
-6,702 Reduced 2.22%
295,426 $23.7 Million
Q3 2019

Nov 14, 2019

SELL
$72.9 - $101.41 $640,207 - $890,582
-8,782 Reduced 2.82%
302,128 $22.2 Million
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $10.9 Million - $14.6 Million
148,811 Added 91.8%
310,910 $29.3 Million
Q1 2019

May 15, 2019

BUY
$48.7 - $86.6 $640,015 - $1.14 Million
13,142 Added 8.82%
162,099 $13 Million
Q4 2018

Feb 14, 2019

SELL
$45.57 - $74.26 $2.92 Million - $4.75 Million
-64,010 Reduced 30.06%
148,957 $8.03 Million
Q3 2018

Dec 21, 2021

BUY
$58.91 - $78.32 $4.65 Million - $6.18 Million
78,967 Added 58.93%
212,967 $16.6 Million
Q3 2018

Nov 14, 2018

SELL
$58.91 - $78.32 $16.2 Million - $21.6 Million
-275,272 Reduced 67.26%
134,000 $10.5 Million
Q2 2018

Apr 21, 2020

BUY
$60.96 - $101.18 $1.75 Million - $2.9 Million
28,684 Added 7.54%
409,272 $26 Million
Q2 2018

Aug 14, 2018

BUY
$60.96 - $101.18 $13.8 Million - $22.9 Million
226,466 Added 146.94%
380,588 $24.2 Million
Q1 2018

Oct 18, 2019

BUY
$73.28 - $102.95 $2.15 Million - $3.03 Million
29,392 Added 23.56%
154,122 $14.1 Million
Q1 2018

May 15, 2018

BUY
$73.28 - $102.95 $838,909 - $1.18 Million
11,448 Added 10.11%
124,730 $11.4 Million
Q4 2017

Feb 14, 2018

BUY
$62.91 - $88.32 $3.59 Million - $5.04 Million
57,102 Added 101.64%
113,282 $8.54 Million
Q3 2017

Nov 14, 2017

BUY
$42.37 - $69.67 $2.38 Million - $3.91 Million
56,180
56,180 $3.91 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.